跳至主要内容
临床试验/EUCTR2009-015058-38-GB
EUCTR2009-015058-38-GB进行中(未招募)1 期

Improving the outcome for patients after osteoporotic femoral fractures - Improving the outcome for patients after osteoporotic femoral fracture

niversity of Leeds0 个研究点目标入组 120 人开始时间: 2010年8月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Patients with acute traumatic trochanteric or supracondylar femoral fractures and fragility fractures (i.e. sustained from standing height or less and radiological features of osteoporosis). - Patients who are aged 55 or older.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • - Patients with open fractures, pathological fractures, ‘floating knee’, associated patellar fractures or simultaneous bilateral fractures - Patients with a known metabolic bone disease, rheumatoid arthritis or chronic renal failure - Patients with dementia - Patients with bone metastases or other malignant bone disease - Patients taking steroids, strontium, biphosphonates or PTH -Patients with oesophageal abnormalities, swallowing problems, hypocalcaemia, hypercalcemia. - Women of child-bearing age (<55years), pregnant or breast feeding.

研究者

发起方
niversity of Leeds

相似试验

Improving the outcome for patients after... | 临床试验